tiprankstipranks
Trending News
More News >
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
US Market
Advertisement

Sonnet BioTherapeutics Holdings (SONN) Income Statement

Compare
611 Followers

Sonnet BioTherapeutics Holdings Income Statement

Last quarter (Q3 2025), Sonnet BioTherapeutics Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Sonnet BioTherapeutics Holdings's net income was $-3.78M. See Sonnet BioTherapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 18.63K$ 147.81K$ 349.94K$ 483.63K$ 0.00
Gross Profit
$ 18.63K$ 147.81K$ -21.09M$ 388.46K$ -58.31K
Operating Expenses
$ 11.87M$ 18.94M$ 8.58M$ 25.57M$ 17.41M
Depreciation and Amortization
$ 83.11K$ 75.75K$ 93.26K$ 95.16K$ 58.31K
EBITDA
$ -11.77M$ -18.72M$ -29.58M$ -24.99M$ -24.24M
Operating Income
$ -11.85M$ -18.79M$ -29.67M$ -25.09M$ -17.41M
Other Income/Expenses
$ 4.41M$ -40.08K$ -52.48K$ 103.47K$ -6.85M
Pretax Income
$ -7.44M$ -18.83M$ -29.72M$ -24.98M$ -24.27M
Net Income
$ -7.44M$ -18.83M$ -29.77M$ -25.01M$ -24.27M
Per Share Metrics
Basic EPS
$ -11.35$ -145.12$ -1.20K$ -2.51K$ -17.16K
Diluted EPS
$ -11.35$ -145.12$ -1.20K$ -2.51K$ -17.16K
Weighted Average Shares Outstanding
655.24K 129.77K 24.70K 9.96K 3.82K
Weighted Average Shares Outstanding (Diluted)
655.24K 129.77K 24.70K 9.96K 3.82K
Currency in USD

Sonnet BioTherapeutics Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis